cbdMD (YCBD) Change in Accured Expenses (2016 - 2025)
cbdMD (YCBD) posted Change in Accured Expenses of -$276942.0 for Q4 2025, down 311.8% sequentially from -$67251.0 in Q3 2025, and down 16.97% YoY from -$333531.2 in Q4 2024.
cbdMD (YCBD) Change in Accured Expenses (2016 - 2025) Analysis & Trends
cbdMD has reported Change in Accured Expenses for 10 years, with the latest figure at -$276942.0 in Q4 2025.
- Quarterly Change in Accured Expenses fell 16.97% year-over-year to -$276942.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$302055.0 (up 79.91% YoY) and the FY2025 annual result came in at -$261883.0, up 76.7% from the prior year.
- Change in Accured Expenses fell to -$276942.0 in Q4 2025 per YCBD's latest filing, from -$67251.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $763157.0 in Q2 2021 and troughed at -$1.6 million in Q3 2024.
- A 5-year average of -$168466.0 and a median of -$53808.0 in 2025 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses plunged 1494.93% in 2023, then soared 20577.44% in 2025.
- Over 5 years, Change in Accured Expenses stood at -$127254.0 in 2021, then jumped by 130.81% to $39204.0 in 2022, then surged by 262.95% to $142292.0 in 2023, then tumbled by 266.4% to -$236770.0 in 2024, then decreased by 16.97% to -$276942.0 in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$276942.0, -$67251.0, and $82503.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -276,942.00 |
| Dec 31, 2025 | -276,942.00 |
| Sep 30, 2025 | -67,251.00 |
| Sep 30, 2025 | -67,251.00 |
| Jun 30, 2025 | 82,503.00 |
| Jun 30, 2025 | 82,503.00 |
| Mar 31, 2025 | -40,365.00 |
| Mar 31, 2025 | -40,365.00 |
| Dec 31, 2024 | -236,770.00 |
| Dec 31, 2024 | -236,770.00 |
| Sep 30, 2024 | -1.57 Mn |
| Sep 30, 2024 | -1.57 Mn |
| Jun 30, 2024 | 399.00 |
| Jun 30, 2024 | 399.00 |
| Mar 31, 2024 | 306,995.00 |
| Mar 31, 2024 | 306,995.00 |
| Dec 31, 2023 | 142,292.00 |
| Dec 31, 2023 | 142,292.00 |
| Sep 30, 2023 | -117,835.00 |
| Sep 30, 2023 | -117,835.00 |